Skip to Main Content

EDIT-301 Program Update: RUBY and EdiTHAL Trial Data Update. Presented in a Company-sponsored Webinar. December 11, 2023.

December 10, 2023

By

Editas Newsroom

Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference

Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering

Editas Medicine Announces Proposed Public Offering